EpicBioCMYK300dpi.png
Epic Bio to Participate in Upcoming Investor Conference
November 07, 2023 06:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized for Broad Therapeutic Applicability
October 26, 2023 11:09 ET | Epic Bio
Epic Bio presented new details on an in-house engineered suite of Cas molecules derived from CasMINI, the smallest Cas known to work in human cells.
EpicBioCMYK300dpi.png
Epic Bio to Present at the Upcoming Annual European Society of Gene and Cell Therapy
October 19, 2023 06:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
Epic Bio Announces the Appointment of Weston Miller, M.D., as Chief Medical Officer
October 17, 2023 06:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
October 05, 2023 09:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
22157.jpg
Global Epigenomics Market Research Report 2023-2031 Featuring Epigenomics AG, Illumina, Merck, Zymo Research, & Agilent Technologies
October 03, 2023 07:03 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global epigenomics market...
EpicBioCMYK300dpi.png
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
September 28, 2023 09:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
September 19, 2023 09:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
September 14, 2023 12:00 ET | Epic Bio
- Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic activators - - Rational engineering produced activators that induce the most...
Global Epigenetic Market
Global Epigenetic Therapeutics Market to Reach $9.8 Billion by 2028 - Projected Revenue Shares for PRAP, Kinase, IDH, HDAC, DNMT, and KMT Inhibitors
June 23, 2023 05:08 ET | Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Epigenetic Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global epigenetic therapeutics market was...